<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04027595</url>
  </required_header>
  <id_info>
    <org_study_id>NSUOCO2020</org_study_id>
    <nct_id>NCT04027595</nct_id>
  </id_info>
  <brief_title>Efficacy and Outcomes of Neodymium-doped Yttrium Aluminum Garnet (Nd: YAG) Laser Capsulotomy Performed by Optometrists</brief_title>
  <official_title>Neodymium-doped Yttrium Aluminum Garnet (Nd: YAG) Laser Capsulotomy: Efficacy and Outcomes Performed by Optometrists</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northeastern State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northeastern State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to formally assess the efficacy and outcomes of
      optometrist-performed neodymium-doped yttrium aluminum garnet (Nd: YAG) laser capsulotomy
      procedures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will undergo a pre-procedure examination to establish baseline findings and to
      determine if they meet the inclusion criteria. Participants will undergo the Nd: YAG laser
      capsulotomy procedure and will be examined at 1 hour, 1 day (if necessary), 1 week, 1 month,
      and 3 months following the procedure. Follow-up examinations will evaluate visual acuity
      improvement and possible post-procedure complications. The complication rate following the
      laser capsulotomy procedure is typically minimal.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 17, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Central Visual Acuity</measure>
    <time_frame>3 months</time_frame>
    <description>Pre and Post Procedure Visual Acuity</description>
  </primary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Posterior Capsule Opacification Obscuring Vision</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Neodymium-doped Yttrium Aluminum Garnet (Nd: YAG) Laser Capsulotomy</intervention_name>
    <description>A Nd: YAG laser will be used to open the cloudy posterior capsule of the lens to improve central visual acuity.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Existing patients at primary eye care optometric facilities.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Ability to provide written informed consent;

          2. At least 18 years of age, male or female;

          3. Prior cataract surgery;

          4. Diagnosed with posterior capsule opacification obstructing vision;

          5. Best-corrected visual acuity less than 20/40 or visual acuity with glare that reduces
             by 2 lines or more on an ETDRS visual acuity chart or significant effect on activities
             of daily living

        Exclusion Criteria:

          1. History of underlying ocular disease (not including mild/moderate non-proliferative
             diabetic retinopathy or incidental findings)

          2. Previous myopic refractive error greater than 6.00 diopters

          3. Complications following previous ocular procedures (i.e. intraocular lens
             decentration)

          4. Ocular surgery other than uncomplicated cataract or uncomplicated refractive surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Spencer D Johnson, OD</last_name>
    <phone>(918)444-4040</phone>
    <email>johns137@nsuok.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nathan Lighthizer, OD</last_name>
    <phone>(918)444-4000</phone>
    <email>lighthiz@nsuok.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Northeastern State University</name>
      <address>
        <city>Tahlequah</city>
        <state>Oklahoma</state>
        <zip>74464</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Spencer D Johnson, OD</last_name>
      <phone>918-444-4040</phone>
      <email>johns137@nsuok.edu</email>
    </contact>
    <contact_backup>
      <last_name>Nathan Lighthizer, OD</last_name>
      <phone>(918)444-4000</phone>
      <email>lighthiz@nsuok.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>July 18, 2019</study_first_submitted>
  <study_first_submitted_qc>July 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 22, 2019</study_first_posted>
  <last_update_submitted>February 26, 2020</last_update_submitted>
  <last_update_submitted_qc>February 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Capsule Opacification</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

